 <h1>Iodixanol Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to iodixanol: injection solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, iodixanol may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking iodixanol:</p><p>
<i>Less common</i>
</p><ul>
<li>Arm, back, or jaw pain</li>
<li>chest pain or discomfort</li>
<li>chest tightness or heaviness</li>
<li>fainting</li>
<li>fast or irregular heartbeat</li>
<li>nausea</li>
<li>sweating</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Agitation</li>
<li>blurred vision</li>
<li>coma</li>
<li>confusion</li>
<li>cough</li>
<li>decreased urine output</li>
<li>depression</li>
<li>difficulty breathing</li>
<li>dilated neck veins</li>
<li>dizziness</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>extreme fatigue</li>
<li>fainting</li>
<li>feeling of warmth</li>
<li>headache</li>
<li>hostility</li>
<li>irregular breathing</li>
<li>irritability</li>
<li>lethargy</li>
<li>muscle twitching</li>
<li>noisy breathing</li>
<li>rapid weight gain</li>
<li>redness of the face, neck, arms, and occasionally, upper chest</li>
<li>seizures</li>
<li>severe or sudden headache</li>
<li>stupor</li>
<li>sudden loss of coordination</li>
<li>sudden slurring of speech</li>
<li>swelling of the face, hands, fingers, lower legs, ankles, or feet</li>
<li>vomiting</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of iodixanol may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Bad, unusual, or unpleasant (after) taste</li>
<li>burning, crawling, itching, numbness, prickling, "pins and needles", tingling feeling</li>
<li>change in taste</li>
<li>diarrhea</li>
<li>feeling of constant movement of self or surroundings</li>
<li>itching or skin rash</li>
<li>sensation of spinning</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Acidic or sour stomach</li>
<li>anxiety</li>
<li>belching</li>
<li>continuing ringing or buzzing or other unexplained noise in the ears</li>
<li>decreased awareness or responsiveness</li>
<li>dry mouth</li>
<li>general feeling of discomfort or illness</li>
<li>hearing loss</li>
<li>heartburn</li>
<li>hives or welts</li>
<li>hyperventilation</li>
<li>indigestion</li>
<li>restlessness</li>
<li>severe sleepiness</li>
<li>shaking</li>
<li>stomach discomfort, upset, or pain</li>
<li>transient, mild, pleasant aromatic odor</li>
</ul><p>
<!-- end injection solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to iodixanol: injectable solution</i></p><h3>General</h3><p>Serious reactions as well as fatalities are only seen on very rare occasions.  Serious adverse reactions may include acute/chronic renal failure, anaphylactic or anaphylactoid shock, hypersensitivity reaction followed by cardiac reactions (Kounis' syndrome), cardiac or cardio-respiratory arrest and myocardial infarction.<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Vaginal hemorrhage (intrathecal)</p>
<p><b>Uncommon</b> (0.1% to 1%): Hematuria<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Angina pectoris, chest pain</p>
<p><b>Uncommon</b> (0.1% to 1%): Arrhythmias, cardiac failure, conduction abnormalities, hypotension, myocardial infarction, flushing, peripheral ischemia.</p>
<p><b>Rare</b> (0.01% to 0.1%): Hypotension</p>
<p><b>Very rare</b> (less than 0.01%): Hypertension, ischemia</p>
<p><b>Frequency not reported</b>: Ventricular hypokinesia, myocardial ischemia, arterial spasm, thrombosis, thrombophlebitis, thrombocytopenia, cardiorespiratory arrest, spasm of coronary arteries, shock<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Nonurticarial rash, erythema, pruritus, rash, urticaria</p>
<p><b>Uncommon</b> (0.1% to 1%): Hematoma, increased sweating</p>
<p><b>Very rare</b> (less than 0.01%): Angioedema</p>
<p><b>Frequency not reported</b>: Severe pustular or bullous skin reactions, Stevens-Johnson syndrome, erythema multiforme, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, drug rash with eosinophilia and systemic symptoms, drug eruption, dermatitis allergic, skin exfoliation<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea</p>
<p><b>Uncommon</b> (0.1% to 1%): Diarrhea, vomiting, dyspepsia</p>
<p><b>Very rare</b> (less than 0.01%): Abdominal pain, abdominal discomfort</p>
<p><b>Frequency not reported</b>: Acute pancreatitis, pancreatitis aggravated, salivary gland enlargement<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Injection site pain<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, migraine, paresthesia</p>
<p><b>Uncommon</b> (0.1% to 1%): Nervousness, dizziness, sensory disturbance, syncope, parosmia, cerebral vascular disorder, convulsions, hypoesthesia, stupor</p>
<p><b>Very rare</b> (less than 0.01%): Cerebrovascular accident, amnesia</p>
<p><b>Frequency not reported</b>: Disturbances in consciousness, coma, motor dysfunction, transient contrast induced encephalopathy (including hallucination), tremor</p>
<p><b>Postmarketing reports</b>: Dyskinesia<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Scotoma</p>
<p><b>Uncommon</b> (0.1% to 1%): Abnormal vision</p>
<p><b>Frequency not reported</b>: Transient blindness<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Vertigo</p>
<p><b>Uncommon</b> (0.1% to 1%): Edema, fatigue, malaise, tinnitus, feeling hot</p>
<p><b>Rare</b> (0.01% to 0.1%): Pain, pyrexia, shivering (chills), administration site reactions including</p>
<p>extravasation</p>
<p><b>Very rare</b> (less than 0.01%): Feeling cold, asthenic conditions</p>
<p><b>Frequency not reported</b>: Iodism<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Pharyngeal edema</p>
<p><b>Frequency not reported</b>: Anaphylactoid reaction, anaphylactoid shock<sup>[Ref]</sup></p><p>Hypersensitivity reactions usually present as respiratory or cutaneous symptoms like dyspnea, rash, erythema, urticaria, pruritus, skin reaction, angioneurotic edema, hypotension, fever, laryngeal edema, bronchospasm or pulmonary edema.  They may appear either immediately after the injection or up to a few days later.</p>
<p>Hypersensitivity reactions may occur irrespectively of the dose and mode of administration and mild symptoms may represent the first signs of a serious anaphylactoid reaction/shock.<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Agitation, anxiety, insomnia, confusion<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Uncommon</b> (0.1% to 1%): Abnormal renal function, acute renal failure<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Uncommon</b> (0.1% to 1%): Asthma, bronchitis, dyspnea, pulmonary edema, rhinitis</p>
<p><b>Rare</b> (less than 0.1%): Cough</p>
<p><b>Frequency not reported</b>: Non-cardiogenic pulmonary edema, respiratory arrest, respiratory failure</p>
<p><b>Postmarketing reports</b>: Pulmonary embolism, respiratory depression<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Rare</b> (less than 0.1%): Back pain</p>
<p><b>Frequency not reported</b>: Arthralgia</p>
<p><b>Postmarketing reports</b>: Polymyalgia rheumatica<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Postmarketing reports</b>: Hemorrhage<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Postmarketing reports</b>: Hypoglycemia<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Visipaque (iodixanol)." Nycomed Inc, Princeton, NJ. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about iodixanol</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>Drug class: non-ionic iodinated contrast media</li>
<li>FDA Alerts (1)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Iodixanol Injection &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Visipaque</dd></dl>
<h3>Professional resources</h3>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Aortography</li>
<li>Cerebral Arteriography</li>
<li>Computed Tomography</li>
<li>Coronary Arteriography</li>
<li data-more-config-id="list-data-resources-conditions">... +5 more</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to iodixanol: injectable solution</i></p><h3>General</h3><p>Serious reactions as well as fatalities are only seen on very rare occasions.  Serious adverse reactions may include acute/chronic renal failure, anaphylactic or anaphylactoid shock, hypersensitivity reaction followed by cardiac reactions (Kounis' syndrome), cardiac or cardio-respiratory arrest and myocardial infarction.<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Vaginal hemorrhage (intrathecal)</p><p><b>Uncommon</b> (0.1% to 1%): Hematuria<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Angina pectoris, chest pain</p><p><b>Uncommon</b> (0.1% to 1%): Arrhythmias, cardiac failure, conduction abnormalities, hypotension, myocardial infarction, flushing, peripheral ischemia.</p><p><b>Rare</b> (0.01% to 0.1%): Hypotension</p><p><b>Very rare</b> (less than 0.01%): Hypertension, ischemia</p><p><b>Frequency not reported</b>: Ventricular hypokinesia, myocardial ischemia, arterial spasm, thrombosis, thrombophlebitis, thrombocytopenia, cardiorespiratory arrest, spasm of coronary arteries, shock<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Nonurticarial rash, erythema, pruritus, rash, urticaria</p><p><b>Uncommon</b> (0.1% to 1%): Hematoma, increased sweating</p><p><b>Very rare</b> (less than 0.01%): Angioedema</p><p><b>Frequency not reported</b>: Severe pustular or bullous skin reactions, Stevens-Johnson syndrome, erythema multiforme, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, drug rash with eosinophilia and systemic symptoms, drug eruption, dermatitis allergic, skin exfoliation<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea</p><p><b>Uncommon</b> (0.1% to 1%): Diarrhea, vomiting, dyspepsia</p><p><b>Very rare</b> (less than 0.01%): Abdominal pain, abdominal discomfort</p><p><b>Frequency not reported</b>: Acute pancreatitis, pancreatitis aggravated, salivary gland enlargement<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Injection site pain<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, migraine, paresthesia</p><p><b>Uncommon</b> (0.1% to 1%): Nervousness, dizziness, sensory disturbance, syncope, parosmia, cerebral vascular disorder, convulsions, hypoesthesia, stupor</p><p><b>Very rare</b> (less than 0.01%): Cerebrovascular accident, amnesia</p><p><b>Frequency not reported</b>: Disturbances in consciousness, coma, motor dysfunction, transient contrast induced encephalopathy (including hallucination), tremor</p><p><b>Postmarketing reports</b>: Dyskinesia<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Scotoma</p><p><b>Uncommon</b> (0.1% to 1%): Abnormal vision</p><p><b>Frequency not reported</b>: Transient blindness<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Vertigo</p><p><b>Uncommon</b> (0.1% to 1%): Edema, fatigue, malaise, tinnitus, feeling hot</p><p><b>Rare</b> (0.01% to 0.1%): Pain, pyrexia, shivering (chills), administration site reactions including</p><p>extravasation</p><p><b>Very rare</b> (less than 0.01%): Feeling cold, asthenic conditions</p><p><b>Frequency not reported</b>: Iodism<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Pharyngeal edema</p><p><b>Frequency not reported</b>: Anaphylactoid reaction, anaphylactoid shock<sup>[Ref]</sup></p><p>Hypersensitivity reactions usually present as respiratory or cutaneous symptoms like dyspnea, rash, erythema, urticaria, pruritus, skin reaction, angioneurotic edema, hypotension, fever, laryngeal edema, bronchospasm or pulmonary edema.  They may appear either immediately after the injection or up to a few days later.</p><p>Hypersensitivity reactions may occur irrespectively of the dose and mode of administration and mild symptoms may represent the first signs of a serious anaphylactoid reaction/shock.<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Agitation, anxiety, insomnia, confusion<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Uncommon</b> (0.1% to 1%): Abnormal renal function, acute renal failure<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Uncommon</b> (0.1% to 1%): Asthma, bronchitis, dyspnea, pulmonary edema, rhinitis</p><p><b>Rare</b> (less than 0.1%): Cough</p><p><b>Frequency not reported</b>: Non-cardiogenic pulmonary edema, respiratory arrest, respiratory failure</p><p><b>Postmarketing reports</b>: Pulmonary embolism, respiratory depression<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Rare</b> (less than 0.1%): Back pain</p><p><b>Frequency not reported</b>: Arthralgia</p><p><b>Postmarketing reports</b>: Polymyalgia rheumatica<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Postmarketing reports</b>: Hemorrhage<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Postmarketing reports</b>: Hypoglycemia<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Visipaque (iodixanol)." Nycomed Inc, Princeton, NJ. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><h2>More about iodixanol</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>Drug class: non-ionic iodinated contrast media</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Iodixanol Injection &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Aortography</li>
<li>Cerebral Arteriography</li>
<li>Computed Tomography</li>
<li>Coronary Arteriography</li>
<li data-more-config-id="list-data-resources-conditions">... +5 more</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>